|
Publications
|
|
Monday, 08 June 2009 11:12 |
In a letter to President Obama, Chairman Waxman praised the President for his support of generic biologics in the FY 2010 Budget, with a term of exclusivity consistent with that granted to other drugs under Waxman-Hatch. Chairman Waxman urged the President to consider what steps can be taken under current law to prepare and even begin to approve safe and effective generic biologics, in advance of legislation. In March, Chairman Waxman introduced H.R. 1427 the "Promoting Innovation and Access to Life-Saving Medicine Act," a bipartisan bill to allow the FDA to approve affordable generic biologic drugs.
Documents
|